Dr. John Junghoon Shin, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 385 Tremont Ave, Veterans Affairs Medical Center, Medical (111), East Orange, NJ 07018 Phone: 973-676-1000 Fax: 973-395-7091 |
Dr. Leonard Marshall Pogach, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 385 Tremont Ave, East Orange, NJ 07018 Phone: 973-676-1000 Fax: 973-395-7111 |
News Archive
Bacterial infection is a major health threat to patients with severe burns and other kinds of serious wounds such as traumatic bone fractures. Recent studies have identified an important new weapon for fighting infection and healing wounds: insulin.
The National Center for Disaster Preparedness, a research, policy and education institution that has worked for the past decade across the United States to strengthen responses to extreme weather, terrorism and other threats, has joined Columbia University's Earth Institute.
Gilead Sciences, Inc. today announced that, in consultation with the U.S. Food and Drug Administration (FDA), the company will amend the design of ongoing clinical trials to discontinue dosing of GS 9190 in hepatitis C-infected patients who are receiving that compound in combination with pegylated interferon and ribavirin, and another direct-acting antiviral agent.
Abbott scientists and independent researchers will highlight the latest research findings on HUMIRA (adalimumab) at this year's American College of Rheumatology (ACR) Annual Scientific Meeting, scheduled for November 5-9 in Chicago.
Although inflammatory bowel disease (IBD) [comprising mainly Crohn's disease (CD) and ulcerative colitis (UC)] is thought to affect about 150 000 people in the United Kingdom, the prevalence of severe IBD is not known. Mortality following hospitalization for IBD is significant but little has been reported on long-term follow-up.
› Verified 4 days ago